文献速递认知障碍与谵妄多重用药

老年人抗抑郁药使用与认知结局:一项前瞻性队列研究

Antidepressant Use and Cognitive Outcomes in Very Old Women.
PubMed 文献 · J Gerontol A Biol Sci Med Sci · 2018-01-01

该研究纳入1234名社区居住老年女性(平均83.2岁),基线记录抗抑郁药使用,5年后由专家小组判定认知状态。结果显示,选择性5-羟色胺再摄取抑制剂(SSRI)使用者的认知下降最大,且SSRI和曲唑酮使用者发生轻度认知障碍或痴呆的风险显著增加。

要点

  • SSRI使用者5年内认知下降最明显。
  • SSRI使用者发生MCI或痴呆的风险是非使用者的2.69倍。
  • 曲唑酮使用者发生MCI或痴呆的风险是非使用者的3.48倍。

核心结论

  • 在高龄老年女性中,使用抗抑郁药尤其是SSRI和曲唑酮,与5年后认知 impairment 风险增加相关。

研究设计与样本

  • 研究为前瞻性队列研究,纳入1234名社区居住老年女性(平均年龄83.2岁),来自骨质疏松性骨折研究。
  • 基线抗抑郁药使用通过药物容器验证,5年后由专家临床小组判定认知状态(正常、MCI或痴呆)。

主要发现

  • SSRI使用者5年内认知下降最大,校正人口学、共病、苯二氮䓬使用和基线认知后仍显著。
  • SSRI使用者发生MCI或痴呆的风险是非使用者的2.69倍(OR=2.69,95%CI=1.64-4.41)。
  • 曲唑酮使用者发生MCI或痴呆的风险是非使用者的3.48倍(OR=3.48,95%CI=1.12-10.81)。
  • 三环类或其他抗抑郁药使用与认知结局无显著关联。

关键数值与推荐

  • SSRI使用者发生MCI或痴呆的OR=2.69(95%CI=1.64-4.41)。
  • 曲唑酮使用者发生MCI或痴呆的OR=3.48(95%CI=1.12-10.81)。

临床怎么用

  • 对高龄老年女性处方SSRI或曲唑酮时,应关注认知功能变化。
  • 使用SSRI或曲唑酮的患者可考虑定期认知评估。

局限性

  • 研究仅纳入社区居住老年女性,结果可能不适用于男性或机构居住者。
  • 抗抑郁药使用为基线记录,未分析用药时长或剂量变化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Antidepressant use is very common in the elderly, but the effects of antidepressants on cognition in the elderly are controversial with some studies suggesting harm and others protection. We aimed to investigate the association between different antidepressant use and change in cognition and risk of mild cognitive impairment (MCI) or dementia in very old women. METHODS: We examined 1,234 community-dwelling women (mean age 83.2 years) from the Study of Osteoporotic Fractures. Baseline antidepressant use was reported and verified by medication containers, and medications were coded with computerized dictionary. Cognitive status (normal, MCI, or dementia) was adjudicated by an expert clinical panel 5 years later. Change in a short-form Mini-Mental State Examination and Trails B were evaluated over 5 years. RESULTS: Eleven per cent of the women were taking antidepressants. Users of selective serotonin reuptake inhibitors (SSRIs) had the greatest cognitive decline over 5 years, after adjustment for demographics, medical comorbidities, benzodiazepine use, and baseline cognition. Multivariable logistic regression shows that the users of SSRIs were more than twice (OR = 2.69, 95% CI = 1.64-4.41) and trazodone users more than three times (3.48, 1.12-10.81) as likely to develop MCI or dementia compared with the nonusers. Further adjustment for baseline cognition or depressive symptoms did not appreciably alter the results, and the association remained after excluding women with high depressive symptoms. The use of tricyclic antidepressants or other antidepressants was not significantly associated with cognitive outcomes. CONCLUSIONS: The use of antidepressants, especially SSRIs and trazodone, was associated with an increased risk of cognitive impairment 5 years later among the oldest old women.

来源:J Gerontol A Biol Sci Med Sci,查看原文。版权归原作者所有。

引用

  1. Leng Y, Diem SJ, Stone KL, et al. Antidepressant Use and Cognitive Outcomes in Very Old Women. J Gerontol A Biol Sci Med Sci. 2018. PMID: 29244058. doi:10.1093/gerona/glx226

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。